Patents by Inventor Raymond Li

Raymond Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12136037
    Abstract: There is provided a non-transitory storage medium and a system for generating an abstractive summary of a document using an abstractive machine learning algorithm (MLA). A document including a plurality of text sequences is received. An extractive summary of the document is generated, the extractive summary including a set of summary text sequences which is a subset of the plurality of text sequences. The abstractive MLA generates, based on the set of summary text sequences and at least a portion of the plurality of text sequences, an abstractive summary of the document including a set of abstractive text sequences, at least one abstractive text sequence not being included in the plurality of text sequences.
    Type: Grant
    Filed: July 19, 2023
    Date of Patent: November 5, 2024
    Assignee: ServiceNow Canada Inc.
    Inventors: Sandeep Subramanian, Raymond Li, Christopher Pal, Jonathan Pilault
  • Publication number: 20240226094
    Abstract: Provided herein are methods for inhibiting ALPK1 kinase activity using a compound of Formula I, and compositions and methods for therapy, for example in treating Kawasaki Disease.
    Type: Application
    Filed: April 19, 2022
    Publication date: July 11, 2024
    Inventors: Yuning WEI, Danyang LIU, Cong XU, Lawrence S. MELVIN, JR., Xiong WEI, Tongruei Raymond LI, Jieqing FAN, Yanfang PAN, Huaixin DANG, Henri LICHENSTEIN, Tian XU
  • Publication number: 20240216362
    Abstract: Provided herein are compounds of Formula (I) or (II) and related compositions and methods for their use as inhibitors of alpha-kinase 1 (ALPK1) and in treating Kawasaki Disease.
    Type: Application
    Filed: April 18, 2022
    Publication date: July 4, 2024
    Inventors: Yuning WEI, Danyang LIU, Cong XU, Lawrence S. MELVIN, Jr., Xiong WEI, Tongruei Raymond LI, Jieqing FAN, Yanfang PAN, Huaixin DANG, Henri LICHENSTEIN, Tian XU
  • Publication number: 20240124511
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Application
    Filed: October 30, 2023
    Publication date: April 18, 2024
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Publication number: 20240116885
    Abstract: Provided are compounds of Formula (I) or (II) and related compositions and methods for their use as inhibitors of alpha-kinase 1 (ALPK1).
    Type: Application
    Filed: September 23, 2021
    Publication date: April 11, 2024
    Inventors: Danyang Liu, Cong Xu, Lawrence S. Melvin, Jr., Xiong Wei, Tongruei Raymond Li, Jieqing Fan, Yanfang Pan, Huaixin Dang, Henri Lichenstein, Tian Xu
  • Publication number: 20240109853
    Abstract: Provided are compounds of Formula I, compositions and methods for their use as inhibitors of alpha-kinase 1 (ALPK1).
    Type: Application
    Filed: September 23, 2021
    Publication date: April 4, 2024
    Inventors: Danyang Liu, Cong Xu, Lawrence S. Melvin, Jr., Xiong Wei, Tongruei Raymond Li, Jieqing Fan, Yanfang Pan, Huaixin Dang, Henri Lichenstein, Tian Xu
  • Publication number: 20240028838
    Abstract: In one aspect, a method of speech signal processing using artificial intelligence, includes receiving, with at least one processor, a digital speech signal, converting, with the at least one processor, the digital speech signal to text, performing self-alignment pre-training of an encoder on entities and their synonyms, label attention training the pretrained encoder by aligning label-text joint representation to that of label synonym-text joint representations, and identifying, with the trained encoder, entities in a span in the text.
    Type: Application
    Filed: July 20, 2023
    Publication date: January 25, 2024
    Inventors: Rhys Compton, Xavier Amatriain, Li Deng, Shengyi Huang, Anitha Kannan, Namit Katariya, Raymond Li, Ilya Valmianski
  • Patent number: 11840551
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: December 12, 2023
    Assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Publication number: 20230394308
    Abstract: There is provided a non-transitory storage medium and a system for generating an abstractive summary of a document using an abstractive machine learning algorithm (MLA). A document including a plurality of text sequences is received. An extractive summary of the document is generated, the extractive summary including a set of summary text sequences which is a subset of the plurality of text sequences. The abstractive MLA generates, based on the set of summary text sequences and at least a portion of the plurality of text sequences, an abstractive summary of the document including a set of abstractive text sequences, at least one abstractive text sequence not being included in the plurality of text sequences.
    Type: Application
    Filed: July 19, 2023
    Publication date: December 7, 2023
    Applicant: ServiceNow Canada Inc.
    Inventors: Sandeep SUBRAMANIAN, Raymond LI, Christopher PAL, Jonathan PILAULT
  • Patent number: 11773131
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: October 3, 2023
    Assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Patent number: 11755909
    Abstract: There is provided a method and a system for training an extractive machine learning algorithm (MLA) to generate extractive summaries of text documents. Reference documents and associated extractive summaries are received. The extractive MLA is then trained to generate an extractive summary, where the training includes, for a given reference document, encoding, using a sentence encoder, a plurality of reference sentences to obtain an associated plurality of sentence representations, encoding, using a document encoder, the associated plurality of sentence representations to obtain a document representation, extracting, using a decoder and based on the associated plurality of sentence representations and the document representation, a first reference sentence of the plurality of reference sentences to obtain a first extracted sentence. A given parameter is updated based on the first extracted sentence and the given reference document summary.
    Type: Grant
    Filed: June 7, 2022
    Date of Patent: September 12, 2023
    Assignee: ServiceNow Canada Inc.
    Inventors: Sandeep Subramanian, Raymond Li, Christopher Pal, Jonathan Pilault
  • Publication number: 20230042305
    Abstract: There is provided a method and system for training and using a transformer language model (TLM) part of a recommendation engine. Natural language discussions about a category of items are received, the discussions comprising tags each indicative of a respective item belonging to the category of item. Information is received for each respective item. Based on the natural language discussions, the tags and the information about the respective item, the TLM is trained to: upon receipt of a user input, determine whether a given item should be recommended based on the user input, if the given item should be recommended, retrieving given information about the given item and generating a response to the user input, the response to the user input comprising the given item to be recommended and the given information, and output the response to the user input. The response is generated in natural language format.
    Type: Application
    Filed: January 7, 2021
    Publication date: February 9, 2023
    Applicant: ServiceNow Canada Inc.
    Inventors: Raymond LI, Christopher PAL
  • Publication number: 20220366251
    Abstract: There is provided a method and a system for training an extractive machine learning algorithm (MLA) to generate extractive summaries of text documents. Reference documents and associated extractive summaries are received. The extractive MLA is then trained to generate an extractive summary, where the training includes, for a given reference document, encoding, using a sentence encoder, a plurality of reference sentences to obtain an associated plurality of sentence representations, encoding, using a document encoder, the associated plurality of sentence representations to obtain a document representation, extracting, using a decoder and based on the associated plurality of sentence representations and the document representation, a first reference sentence of the plurality of reference sentences to obtain a first extracted sentence. A given parameter is updated based on the first extracted sentence and the given reference document summary.
    Type: Application
    Filed: June 7, 2022
    Publication date: November 17, 2022
    Applicant: ServiceNow Canada Inc.
    Inventors: Sandeep SUBRAMANIAN, Raymond LI, Christopher PAL, Jonathan PILAULT
  • Patent number: 11397892
    Abstract: A method and a system for generating an abstractive summary of a document using an abstractive machine learning algorithm (MLA) and a method and a system for training the abstractive MLA. A document including a plurality of text sequences is received. An extractive summary of the document is generated, the extractive summary including a set of summary text sequences which is a subset of the plurality of text sequences. The abstractive MLA generates, based on the set of summary text sequences and at least a portion of the plurality of text sequences, an abstractive summary of the document including a set of abstractive text sequences, at least one abstractive text sequence not being included in the plurality of text sequences. In some aspects, the extractive summary is generated by an extractive MLA having been trained to generate extractive summaries.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: July 26, 2022
    Assignee: SERVICENOW CANADA INC.
    Inventors: Sandeep Subramanian, Raymond Li, Jonathan Pilault, Christophe Pal
  • Publication number: 20220017560
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Application
    Filed: August 16, 2021
    Publication date: January 20, 2022
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Publication number: 20210403501
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 30, 2021
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Patent number: 11186606
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: November 30, 2021
    Assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Publication number: 20210365773
    Abstract: A method and a system for generating an abstractive summary of a document using an abstractive machine learning algorithm (MLA) and a method and a system for training the abstractive MLA. A document including a plurality of text sequences is received. An extractive summary of the document is generated, the extractive summary including a set of summary text sequences which is a subset of the plurality of text sequences. The abstractive MLA generates, based on the set of summary text sequences and at least a portion of the plurality of text sequences, an abstractive summary of the document including a set of abstractive text sequences, at least one abstractive text sequence not being included in the plurality of text sequences. In some aspects, the extractive summary is generated by an extractive MLA having been trained to generate extractive summaries.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 25, 2021
    Applicant: Element AI Inc.
    Inventors: Sandeep SUBRAMANIAN, Raymond LI, Jonathan PILAULT, Christophe PAL
  • Patent number: 11149051
    Abstract: The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: October 19, 2021
    Assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.
    Inventors: Tian Xu, Cong Xu, Danyang Liu, Jieqing Fan, Yanfang Pan, Tongruei Raymond Li, Xiaodong Chen
  • Patent number: 10868416
    Abstract: An electronic protection circuit includes a resettable fuse such as a positive temperature coefficient (PTC) thermistor or polymer PTC device. The resettable fuse enters a high-resistance tripped state in response to an overcurrent condition. One or more electrically controllable switches are placed in series with the resettable fuse. A monitoring and control circuit monitors voltage across the resettable fuse and to opens the switches when the voltage is outside of a predetermined range. The switches can remain open after the overcurrent event is resolved in order to allow the resettable fuse time to reset.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: December 15, 2020
    Assignee: Sierra Wireless, Inc.
    Inventor: Raymond Li